TERSI

Manufacturer: Quinnova Pharmaceuticals, Inc.
Effective date: 2009-12-04
Label type: NON-STANDARDIZED ALLERGENIC LABEL
Version: 5
Source: full-release
Hydrated at: 2026-06-01 02:47:26

Label at a glance#

ProductTERSI

Active ingredientSELENIUM SULFIDE

Label structure13 sections

Indications and uses

For the treatment of seborrheic dermatitis and tinea versicolor of the skin.

Dosage and administration

Unless otherwise directed by a prescribing physician,TERSI should be applied to affected area twice a day.TERSI should be rubbed into the skin until it is completely absorbed. TERSI should be shaken vigorously before each application and inverted to administer.

Contacts and useful links#

Websitewww.quinnova.com

www.QUINNOVA.com

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

TERSI Hydrating Topical Foam

(selenium sulfide in a water and lipid based foam, 2.25%)

Rx Only

DESCRIPTION

DESCRIPTION SECTION

TERSI, which is applied topically, is an antiseborrheic, antifungal preparation for the treatment of seborrheic dermatitis and tinea versicolor of the skin. Each gram of TERSI contains selenium sulfide 2.25% as the active ingredient, and the following inactive ingredients: dimethicone, ethylparaben, glycerin, methylparaben, phenoxyethanol, polysorbate 20, povidone, propylene glycol, propylparaben, purified water, stearic acid, trolamine, and in propellants butane and propane.

CHEMICAL STRUCTURE

SPL UNCLASSIFIED SECTION

Selenium sulfide has the following chemical structure:

chemical-structure

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Topically applied selenium sulfide appears to have a cytostatic effect on cells of the epidermis, reducing corneocyte production.

PHARMACOKINETICS

PHARMACOKINETICS SECTION

The mechanism of action of topically applied selenium sulfide is not yet known.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

For the treatment of seborrheic dermatitis and tinea versicolor of the skin.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Known hypersensitivity to any of the listed ingredients.

WARNINGS

WARNINGS SECTION

TERSI is for external use only. It is not for ophthalmic, oral, anal or intravaginal use. Contact with eyes, lips, broken or inflamed skin, and all mucous membranes should be avoided. TERSI should not be used by persons who have a known hypersensitivity to selenium sulfide or any of the other listed ingredients.

PRECAUTIONS

PRECAUTIONS SECTION

TERSI should be used only as directed by a physician and should not be used to treat any condition other than that for which it is prescribed.TERSI should not be used on any skin area where inflammation or exudation is present as increased absorption may occur. If redness or irritation occurs, discontinue use and consult with prescribing physician.

Pregnancy (Category C)

PREGNANCY SECTION

Animal reproduction studies have not been performed with topically applied selenium sulfide and it is not known whether TERSI can cause fetal harm when administered to a pregnant woman. Nevertheless, TERSI should be used by a pregnant woman only if necessary.

Nursing Mothers

NURSING MOTHERS SECTION

It is not known whether topically applied selenium sulfide is excreted in human milk. Due to the fact that many drugs are excreted in human milk, caution should be exercised by physicians when administering TERSI to nursing mothers.
KEEP THIS AND ALL OTHER MEDICATIONS OUT OF THE REACH OF CHILDREN.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Transient stinging, burning, itching or irritation is possible.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Unless otherwise directed by a prescribing physician,TERSI should be applied to affected area twice a day.TERSI should be rubbed into the skin until it is completely absorbed.

TERSI should be shaken vigorously before each application and inverted to administer.

canister-inverted

HOW SUPPLIED

HOW SUPPLIED SECTION

TERSI is supplied in a 70 gram or 2.5 ounce aerosolized canister bearing the NDC Number 23710-225-70 and a 10 gram or 0.36 ounce aerosolized canister bearing the NDC Number 23710-025-01. The 10 gram canister is physician dispensed sample product.

Store at controlled room temperature 15º - 25ºC (59º - 77ºF).

Contains flammable materials. Contents under pressure. Do not puncture or incinerate. Do not expose to temperatures over 120ºF [48ºC] even when empty. Keep out of reach of children.

SPL UNCLASSIFIED SECTION

TERSI is covered by U.S. Patent 5,993,830.

TERSI is manufactured for Quinnova Pharmaceuticals, Inc., Newtown, PA 18940, (877) 6606263, www.QUINNOVA.com.

Prescribing Information as of September2007.

company-logo

TRSFO025 7/08

Can Label

SPL UNCLASSIFIED SECTION

Folding Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
727147	selenium sulfide 2.25 % Topical Foam	PSN	5
745768	Tersi Foam 2.25 % Topical Foam	PSN	5
745768	selenium sulfide 22.5 MG/ML Topical Foam [Tersi Foam]	SBD	5
727147	selenium sulfide 22.5 MG/ML Topical Foam	SCD	5
727147	selenium sulfide 2.25 % Topical Foam	SY	5
745768	Tersi Foam 2.25 % Topical Foam	SY	5
745768	Tersi Foam 22.5 MG/ML Topical Foam	SY	5

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
86fffa7b-d382-4771-a253-25cccb64b590	Product name	3	20251124
0306390c-dd77-4363-afe0-63c58088b2a1	Product name	1	20220120
503ea967-4b9c-48cf-9e87-c7975295849d	Product name	2	20220120

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
23710-225-01	2019-10-29	C162847	48780-1	960f7f55-c3a1-8e05-e053-dbdaa90a074a	TERSI
23710-225-70	2019-10-29	C162847	48780-1	960f7f55-c3a1-8e05-e053-dbdaa90a074a	TERSI

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
23710-225-01	TERSI	10 g in 1 CANISTER	AEROSOL, FOAM	10		5
23710-225-70	TERSI	70 g in 1 CANISTER	AEROSOL, FOAM	70		5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
23710-225	TERSI (SELENIUM SULFIDE) AEROSOL, FOAM [QUINNOVA PHARMACEUTICALS, INC.]	5	Legacy NDC, 2 package rows	20101208_4b0c6317-7473-45de-b704-5d48d5c2dbe9.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
23710-225-70	GM - Gram	23710-225	a791c39c-19e7-4e05-886c-0eaa77365bf3	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
SELENIUM SULFIDE	ACTIVE INGREDIENT	Z69D9E381Q	5
SELENIUM	ACTIVE MOIETY	H6241UJ22B	5
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	5
ETHYLPARABEN	INACTIVE INGREDIENT	14255EXE39	5
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	5
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	5
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	5
POLYSORBATE 20	INACTIVE INGREDIENT	7T1F30V5YH	5
POVIDONE K29/32	INACTIVE INGREDIENT	390RMW2PEQ	5
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	5
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	5
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	5
TROLAMINE	INACTIVE INGREDIENT	9O3K93S3TK	5
WATER	INACTIVE INGREDIENT	059QF0KO0R	5

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

TERSI
selenium sulfide
SELENIUM
POVIDONE K29/32
STEARIC ACID
PROPYLENE GLYCOL
GLYCERIN
DIMETHICONE
POLYSORBATE 20
ETHYLPARABEN
PROPYLPARABEN
PHENOXYETHANOL
METHYLPARABEN
WATER
TROLAMINE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
23710-225	23710-225-70, 23710-225-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SELENIUM SULFIDE	Z69D9E381Q	ACTIB
POVIDONE K29/32	390RMW2PEQ	IACT
STEARIC ACID	4ELV7Z65AP	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
GLYCERIN	PDC6A3C0OX	IACT
DIMETHICONE	92RU3N3Y1O	IACT
POLYSORBATE 20	7T1F30V5YH	IACT
ETHYLPARABEN	14255EXE39	IACT
PROPYLPARABEN	Z8IX2SC1OH	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
METHYLPARABEN	A2I8C7HI9T	IACT
WATER	059QF0KO0R	IACT
TROLAMINE	9O3K93S3TK	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 7 · 389 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
GLYCERIN	GLYCERIN	PDC6A3C0OX	FILM, EXTENDED RELEASE / TRANSDERMAL	306.2 mg		Exact identifier — unii candidate 75 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	GEL / TOPICAL		4522 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / PERINEURAL		80 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	CREAM / VAGINAL		56 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	TAMPON / VAGINAL	62.1 mg		Exact identifier — unii candidate 81 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SPRAY / NASAL	22.3 mg/1ml		Exact identifier — unii candidate 75 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION / DENTAL	2 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SPONGE / TOPICAL	2 %w/w		Exact identifier — unii candidate 75 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SPRAY / TOPICAL	0.8 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
POLYSORBATE 20	POLYSORBATE 20	7T1F30V5YH	SHAMPOO / TOPICAL	8 %w/w		Exact identifier — unii candidate 28 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	CREAM / TOPICAL	1 %w/w		Exact identifier — unii candidate 22 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	TABLET, COATED / ORAL	42.4 mg		Exact identifier — unii candidate 26 equally ranked IID candidates
POLYSORBATE 20	POLYSORBATE 20	7T1F30V5YH	SOLUTION / TOPICAL	15 %w/w		Exact identifier — unii candidate 28 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	LIQUID / ORAL		29008 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	OINTMENT / TOPICAL		29 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	OINTMENT / TOPICAL	15 %w/w		Exact identifier — unii candidate 26 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	DROPS / AURICULAR (OTIC)	0.01 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION/ DROPS / OPHTHALMIC	0.75 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	FILM, SOLUBLE / BUCCAL		1 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	TABLET, DELAYED RELEASE / ORAL		36 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / RECTAL		1808 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	INJECTION, SOLUTION / INTRAMUSCULAR		4000 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION, EXTENDED RELEASE / ORAL		1000 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	CREAM, AUGMENTED / TOPICAL		10 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	PASTE / DENTAL	0.5 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	DROPS / ORAL	1 mg/1ml		Exact identifier — unii candidate 79 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	AEROSOL, FOAM / VAGINAL	2 %w/w		Exact identifier — unii candidate 22 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION / AURICULAR (OTIC)	56.55 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	POWDER / ORAL	NA		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / RECTAL	0.13 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / EPIDURAL	1 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	TABLET, CHEWABLE / ORAL		12 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION / OPHTHALMIC	0.6 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	TABLET, DELAYED RELEASE / ORAL		80 mg	Exact identifier — unii candidate 26 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	GEL / OPHTHALMIC	0.44 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	CAPSULE, EXTENDED RELEASE / ORAL	0.22 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	LIQUID / TOPICAL	NA		Exact identifier — unii candidate 22 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		19 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
POLYSORBATE 20	POLYSORBATE 20	7T1F30V5YH	TABLET / ORAL		17 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	AEROSOL, FOAM / TOPICAL		72 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
POLYSORBATE 20	POLYSORBATE 20	7T1F30V5YH	CLOTH / TOPICAL	NA		Exact identifier — unii candidate 28 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION/ DROPS / OPHTHALMIC	0.75 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	DOUCHE / VAGINAL	1 %w/w		Exact identifier — unii candidate 75 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION / OPHTHALMIC	1 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / ORAL		388 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
POLYSORBATE 20	POLYSORBATE 20	7T1F30V5YH	AEROSOL, FOAM / VAGINAL	3 %w/w		Exact identifier — unii candidate 28 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / TOPICAL		216 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SUSPENSION/ DROPS / OPHTHALMIC	2.5 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	PASTE / ORAL		3822 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SHAMPOO, SUSPENSION / TOPICAL	2 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
POLYSORBATE 20	POLYSORBATE 20	7T1F30V5YH	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 28 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION/ DROPS / TOPICAL	0.75 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	GEL, METERED / TOPICAL		20 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / PARENTERAL		18 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	LOTION / TOPICAL		140 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	INJECTION / SUBCUTANEOUS		450 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
POLYSORBATE 20	POLYSORBATE 20	7T1F30V5YH	SUSPENSION / AURICULAR (OTIC)	0.1 %w/v		Exact identifier — unii candidate 28 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CAPSULE, COATED / ORAL	14.21 mg		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	MOUTHWASH / BUCCAL	100 mg/1ml		Exact identifier — unii candidate 75 equally ranked IID candidates
POLYSORBATE 20	POLYSORBATE 20	7T1F30V5YH	LOTION / TOPICAL		2000 mg	Exact identifier — unii candidate 28 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 3 · 43 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Dermoia Seborrheic Dermatitis Selenium Sulfide	SELENIUM SULFIDE	TREASUREWISE LLC	04b8532e-44a7-4eaf-a46d-87611ec93c24	2026-06-23	Warnings	Name fallback generic name: SELENIUM SULFIDE
Silvagle Selenium Sulfide Anti DandruffShampoo	SELENIUM SULFIDE	GUANGZHOU BAOSIJIE BIOTECHNOLOGY CO., LTD	54885ae3-7e2f-7bd2-e063-6394a90a97fe	2026-06-18	Warnings	Name fallback generic name: SELENIUM SULFIDE
CVS Health MAXIMUM STRENGTH Dandruff Medicated Anti-Seborrheic Dermatitis, anti-dandruff	SELENIUM SULFIDE	CVS Health	307e4b16-10ab-44f4-86b9-709d10566d4c	2026-06-04	Warnings	Name fallback generic name: SELENIUM SULFIDE
CVS Gold	SELENIUM SULFIDE	Apollo Health and Beauty Care	1d12ca6a-2734-0534-e063-6294a90a2706	2026-05-08	Warnings	Name fallback generic name: SELENIUM SULFIDE
Dandruff	SELENIUM SULFIDE	H E B	182ca790-0713-412a-9111-c0cf40f20d02	2026-02-24	Warnings, Adverse reactions	Name fallback generic name: SELENIUM SULFIDE
Dandruff	SELENIUM SULFIDE	Meijer, Inc.	c0e4f8cb-74fc-4c0d-9721-f87aa2aa1992	2026-02-19	Warnings, Adverse reactions	Name fallback generic name: SELENIUM SULFIDE
Selsun Blue 2-in-1	SELENIUM SULFIDE	Chattem, Inc.	f97e458c-cce3-498f-81fc-1b96a4e8f50a	2026-02-18	Warnings	Name fallback generic name: SELENIUM SULFIDE
Head and Shoulders Clinical Strength Dandruff Defense Intensive Itch Relief	SELENIUM SULFIDE	The Procter & Gamble Manufacturing Company	b6ad7707-9d02-31a6-e053-2a95a90ae7ad	2025-12-31	Warnings	Name fallback generic name: SELENIUM SULFIDE
Head and Shoulders 2in1 Clinical Strength Dandruff Defense Intensive Itch Relief	SELENIUM SULFIDE	The Procter & Gamble Manufacturing Company	b6ada541-f12b-76f2-e053-2a95a90a5286	2025-12-31	Warnings	Name fallback generic name: SELENIUM SULFIDE
SELENIUM SULFIDE	SELENIUM SULFIDE	KMM Pharmaceuticals, LLC	d9165c56-4c78-8d5a-e053-2995a90a6b2e	2025-12-18	Warnings, Adverse reactions	Name fallback generic name: SELENIUM SULFIDE
Head and Shoulders Clinical Strength Dandruff Defense Dry Scalp Rescue	SELENIUM SULFIDE	The Procter & Gamble Manufacturing Company	b69c4d1f-379f-be92-e053-2995a90ab7ad	2025-12-16	Warnings	Name fallback generic name: SELENIUM SULFIDE
Selenium Sulfide	SELENIUM SULFIDE	Laser Pharmaceuticals, LLC	a72001ce-42a2-4708-e053-2995a90a7593	2025-11-06	Warnings, Adverse reactions	Name fallback generic name: SELENIUM SULFIDE
Selenium Sulfide	SELENIUM SULFIDE	Laser Pharmaceuticals, LLC	dc6609b4-1757-3a13-e053-2995a90ac172	2025-11-06	Warnings, Adverse reactions	Name fallback generic name: SELENIUM SULFIDE
Head and Shoulders Clinical Strength Cooling Itch Relief	SELENIUM SULFIDE	The Procter & Gamble Manufacturing Company	40464e2d-f738-33ec-e063-6394a90a02c2	2025-10-03	Warnings	Name fallback generic name: SELENIUM SULFIDE
Head and Shoulders 2in1 Clinical Strength Cooling Itch Relief	SELENIUM SULFIDE	The Procter & Gamble Manufacturing Company	4046c345-e1ac-0ecc-e063-6294a90a59fa	2025-10-03	Warnings	Name fallback generic name: SELENIUM SULFIDE
Head and Shoulders Clinical Strength Dandruff Defense Advanced Oil Control	SELENIUM SULFIDE	The Procter & Gamble Manufacturing Company	b6ad107b-024b-828f-e053-2995a90aae36	2025-09-04	Warnings	Name fallback generic name: SELENIUM SULFIDE
SELENIUM SULFIDE	SELENIUM SULFIDE	Cintex Services, LLC	3999e3e3-1c1b-bcf7-e063-6394a90aed50	2025-07-10	Warnings, Adverse reactions	Name fallback generic name: SELENIUM SULFIDE
SELENIUM SULFIDE	SELENIUM SULFIDE	Padagis Israel Pharmaceuticals Ltd	28b84e3c-ae44-40bb-93c4-2625e19f7e61	2025-05-31	Warnings, Adverse reactions	Name fallback generic name: SELENIUM SULFIDE
Selenium Sulfide	SELENIUM SULFIDE	Westminster Pharmaceuticals, LLC	9fcab751-28f4-485a-aa37-169318a61110	2025-04-23	Warnings, Adverse reactions	Name fallback generic name: SELENIUM SULFIDE
Head and Shoulders Clinical Strength Dry Scalp Rescue	SELENIUM SULFIDE	The Procter & Gamble Manufacturing Company	3272a482-3813-63e4-e063-6394a90a43eb	2025-04-10	Warnings	Name fallback generic name: SELENIUM SULFIDE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.